SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-128818
Filing Date
2020-04-30
Accepted
2020-04-30 16:22:13
Documents
17
Period of Report
2020-04-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d857739d8k.htm   iXBRL 8-K 30459
2 EX-1.1 d857739dex11.htm EX-1.1 141787
3 EX-4.2 d857739dex42.htm EX-4.2 148800
4 EX-5.1 d857739dex51.htm EX-5.1 14826
8 GRAPHIC g857739g0430030203730.jpg GRAPHIC 1674
9 GRAPHIC g857739g61m31.jpg GRAPHIC 4437
  Complete submission text file 0001193125-20-128818.txt   539827

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA biib-20200427.xsd EX-101.SCH 3076
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20200427_lab.xml EX-101.LAB 17374
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20200427_pre.xml EX-101.PRE 10957
16 EXTRACTED XBRL INSTANCE DOCUMENT d857739d8k_htm.xml XML 3210
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 20835980
SIC: 2836 Biological Products, (No Diagnostic Substances)